Investment Case for a Comprehensive Package of Interventions Against Hepatitis B in China: Applied Modeling to Help National Strategy Planning.

Nayagam S, Chan P, Zhao K, Sicuri E, Wang X, Jia J, Wei L, Walsh N, Rodewald LE, Zhang G, Ailing W, Zhang L, Chang JH, Hou W, Qiu Y, Sui B, Xiao Y, Zhuang H, Thursz MR, Scano F, Low-Beer D, Schwartländer B, Wang Y, Hallett TB

Open source

DOI: 10.1093/cid/ciaa134
Published: 2021 Mar 1
Container: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/cid/ciaa134,
  title = {Investment Case for a Comprehensive Package of Interventions Against Hepatitis B in China: Applied Modeling to Help National Strategy Planning.},
  author = {Nayagam S and Chan P and Zhao K and Sicuri E and Wang X and Jia J and Wei L and Walsh N and Rodewald LE and Zhang G and Ailing W and Zhang L and Chang JH and Hou W and Qiu Y and Sui B and Xiao Y and Zhuang H and Thursz MR and Scano F and Low-Beer D and Schwartländer B and Wang Y and Hallett TB},
  year = {2021},
  journal = {Clinical infectious diseases : an official publication of the Infectious Diseases Society of America},
  doi = {10.1093/cid/ciaa134},
  url = {https://doi.org/10.1093/cid/ciaa134}
}

RIS

TY  - JOUR
TI  - Investment Case for a Comprehensive Package of Interventions Against Hepatitis B in China: Applied Modeling to Help National Strategy Planning.
AU  - Nayagam S
AU  - Chan P
AU  - Zhao K
AU  - Sicuri E
AU  - Wang X
AU  - Jia J
AU  - Wei L
AU  - Walsh N
AU  - Rodewald LE
AU  - Zhang G
AU  - Ailing W
AU  - Zhang L
AU  - Chang JH
AU  - Hou W
AU  - Qiu Y
AU  - Sui B
AU  - Xiao Y
AU  - Zhuang H
AU  - Thursz MR
AU  - Scano F
AU  - Low-Beer D
AU  - Schwartländer B
AU  - Wang Y
AU  - Hallett TB
PY  - 2021
JO  - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
DO  - 10.1093/cid/ciaa134
UR  - https://doi.org/10.1093/cid/ciaa134
ER  -

APA

S, N., P, C., K, Z., E, S., X, W., J, J., L, W., N, W., LE, R., G, Z., W, A., L, Z., JH, C., W, H., Y, Q., B, S., Y, X., H, Z., MR, T., F, S., D, L., B, S., Y, W., & TB, H. (2021). Investment Case for a Comprehensive Package of Interventions Against Hepatitis B in China: Applied Modeling to Help National Strategy Planning.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. https://doi.org/10.1093/cid/ciaa134

Source records

pubmed · retrieved 2026-09-27T09:39:10.036Z